Carbachol is a medicine that helps relax muscles, especially in the eye and bladder. It's used to treat conditions like glaucoma (high pressure in the eye) and overactive bladder. It works by blocking nerve signals that cause muscle contraction.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Carbachol is a prescription eye medicine that makes the pupil smaller. In the US it is now used in two quite different ways. Yuvezzi is a once-daily eye drop that combines carbachol with brimonidine. It is approved for adults with presbyopia, the gradual loss of close-up focusing that usually becomes noticeable in middle age and makes reading small print or a phone screen harder without reading glasses. The drops can sharpen near vision for part of the day, but they do not reverse presbyopia. Miostat is a very dilute carbachol solution that an eye surgeon places inside the eye during surgery, most often cataract surgery, to shrink the pupil. It also reduces the rise in eye pressure that can happen in the first day after cataract surgery. People do not use it at home. Older carbachol eye drops, sold under names such as Isopto Carbachol, were used for decades to lower eye pressure in glaucoma. They no longer appear in the current US Food and Drug Administration (FDA) listing of marketed drug products, and several other groups of glaucoma drops are available.
Carbachol mimics acetylcholine, a chemical messenger that tells the ring-shaped muscle of the iris to tighten. When that muscle contracts, the pupil narrows. A small pupil works like a pinhole camera: it blocks the scattered light that blurs close objects and increases the range of distances that look sharp, so near vision improves even though the eye's lens is no more flexible than before. In Yuvezzi, brimonidine (a medicine also used in some glaucoma drops) relaxes the muscle that widens the pupil. This helps carbachol keep the pupil small and focuses its effect on the pupil rather than on the eye's focusing muscle. In studies, the combination worked better than either ingredient alone. During surgery, the same pupil-narrowing effect helps protect and position structures inside the eye. Carbachol also lowers eye pressure, although exactly how it does so is not fully understood.
Yuvezzi comes in single-use vials. The usual dose is one drop in each eye once a day, and one vial is enough for both eyes. Throw the opened vial away right after use, and avoid touching the tip to the eye, eyelids or any other surface, which can injure the eye or contaminate the drop. Take contact lenses out before using the drops and wait 10 minutes before putting them back in. If you use other eye drops, space them at least 5 minutes apart. Miostat is given only in the operating room. The surgeon draws a small amount into a syringe and places it inside the front of the eye, and the pupil usually narrows within two to five minutes.
With Yuvezzi, the most common problems in studies were stinging or irritation when the drop goes in, eye pain, headache and temporary changes in how clearly things look. Most were mild and went away on their own. Because a smaller pupil lets in less light, vision can look dim or dark, especially in a dim room or at night. Carbachol can also cause a temporary spasm of the eye's focusing muscle, which can blur vision. Do not drive or operate machinery when vision is not clear, and take particular care with night driving. Rarely, drops that shrink the pupil have been linked to a tear or detachment of the retina, the light-sensing layer at the back of the eye. Sudden flashes of light, a sudden shower of new floaters or a shadow or loss of vision need immediate care from an eye doctor, because a detached retina is a medical emergency that can cause permanent vision loss if it is not treated promptly. After surgery with Miostat, problems such as corneal swelling or clouding, inflammation inside the eye, eye pain and longer-lasting pupil narrowing have been reported. Whole-body effects such as flushing, sweating, stomach upset or cramps and headache are possible but uncommon at the small doses used in the eye. Report anything unexpected after eye surgery to the surgical team.
Before starting Yuvezzi, an eye doctor should examine the retina, because people with existing retinal disease have a higher risk of retinal tears and detachment. The drops are not recommended when iritis (inflammation of the colored part of the eye) is present, because narrowing the pupil can worsen scarring between the iris and the lens. The brimonidine in Yuvezzi can lower blood pressure, so let the prescriber know about blood pressure medicines and heart medicines such as digoxin. Brimonidine can add to the effects of alcohol and sedating medicines, including opioid pain medicines and sleeping pills. Caution is also advised with monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants, two older groups of antidepressants. People with conditions that involve poor blood flow, such as Raynaud's phenomenon, heart or brain circulation problems, or dizziness on standing, should discuss whether the drops are suitable. There are no adequate studies of carbachol in pregnancy, so it is used only when the benefit is thought to justify the risk. For surgery, tell the team about a latex allergy, because the Miostat vial stopper contains natural rubber latex, and mention asthma, heart failure, an overactive thyroid, stomach ulcers, urinary blockage or Parkinson's disease, since carbachol's effects on the rest of the body call for caution in these conditions.
In the main studies of Yuvezzi, people aged 45 to 80 were tested on reading an eye chart in dim lighting. About a third to a half gained at least three lines of near vision, without losing distance vision, at one to two hours after a drop, compared with about 4 percent of those who used a placebo drop. The effect was strongest in the first few hours and faded through the day, with fewer people still showing that gain at eight hours. Many people still use reading glasses for some tasks. The drops work only while you use them. Stopping simply returns near vision to where it was. The studies followed people for up to a year, so long-term experience is still limited, and periodic eye checks make sense. With Miostat, the pupil stays small for a while after surgery, which can make vision dimmer at first. Follow-up visits after the operation check eye pressure and healing.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Carbachol, what you've noticed, or ask the community a question.